Insights into adenosine A1 and A3 receptors function: Cardiotoxicity and cardioprotection

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 324-337

  Shneyvays, Vladimir ^a   Safran, Noam ^a   Halili Rutman, Irit ^a   Shainberg, Asher ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Adenosine receptors; Apoptosis; Cardiomyocytes; Cardioprotection; Doxorubicin; Hypoxia

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; DOXORUBICIN;

APOPTOSIS; CARDIOTOXICITY; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; ISCHEMIA; MITOCHONDRIAL MEMBRANE; OXIDATION REDUCTION REACTION; REVIEW;

EID: 0033814185     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<324::aid-ddr16>3.0.co;2-b     Document Type: Review

References (124)

1. Purinergic signalling: Pathophysiological roles
2. 3 receptor: Pathophysiological significance and therapeutic implications for neurodegenerative disorders
3. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
4. Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I
5. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of ihhibition of ceramide generation
6. 3 receptor involvement
7. Adenosine receptor subtypes in the heart: Therapeutic opportunities and challenges
8. Cab nine mast cell adenosine receptors: Cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor
9. Selective activation of A3 adenosine receptors with N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits
10. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model
11. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation
12. Apoptosis by 2-chloro-2'-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells
13. Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow
14. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
15. Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy
16. Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway
17. Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis
18. Mitochondrial production of superoxide radical and hydrogen peroxide
19. Oxidative stress as a mediator of apoptosis
20. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia
21. Improved functional recovew by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart
22. Purines and their roles in apoptosis
23. Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes
24. Apoptosis in chronic hibernating myocardium: Sleeping to death?
25. Adenosine and the anti-infarct effects of preconditioning
26. Adenosine inhibits growth of human aortic smooth muscle cells via A(2B) receptors
27. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: Role of A(2B) receptors
28. Protective effects of adenosine in myocardial ischemia
29. Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas
30. Signal transduction by G proteins in cardiac tissues
31. Plasma adenosine levels increase in patients with chronic heart failure
32. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
33. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
34. Resistance to adriamycin: Relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia
35. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
36. Mitochondria and apoptosis
37. Do ATP-sensitive potassium channels play a role in myocardial stunning?
38. Reduction of acute adrlamycin toxicity in mice treated with adenosine
39. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells
40. Effect of adriamycin, copper and adenosine on calcium transient changes in rat cardiomyocytes
41. Inhibition of calcium accumulation by the sarcoplasmic reticulum: A putative mechanism for the cardiotoxicity of adriamycin
42. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat
43. Ischemic preconditioning: Bioenergetic and metabolic changes and the role of endogenous adenosine
44. Xanthine oxidase: A critical mediator of myocardial injury during ischemia and reperfusion?
45. The role of the cytoskeleton in heart failure
46. Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex
47. Thermal preconditioning protects ratcardiac muscle cells from doxorubicin-induced apoptosis
48. Adenosine A3 receptors: Novel ligands and paradoxical effects
49. Normal and abnormal consequences of apoptosis in the human heart
50. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
51. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart
52. Redox regulation of cellular signalling
53. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair
54. Study of regulation of mitochondrial respiration in vivo: An analysis of influence of ADP diffusion and possible role of cytoskeleton
55. Shrinkage necrosis: A distinct mode of cellular death
56. Anatomical methods in cell death
57. Apoptosis: A basle biological phenomenon with wide-ranging implications in tissue kinetics
58. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor agonists
59. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: The role of reactive oxygen and nitrogen intermediates
60. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
61. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin
62. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and C1-IB-MECA
63. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists
64. Myocardial protection with preconditioning
65. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts
66. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle
67. Adenosine A(2a) and A(2b) receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation
68. 3 receptor: Sustained cardioprotection
69. Ischemic preconditioning protects against infarction in rat heart
70. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival
71. Adenosine acts as an endogenous activator of the cellular antioxidant defense system
72. Apoptosis, oncosis, and necrosis: An overview of cell death
73. Establishment of beta-adrenergic modulation of L-type Ca2+ current in the early stages of cardiomyocyte development
74. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin: Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity
75. Ca2+ as a mediator of ischemic proconditioning
76. Role of adenosine in the heart circulation
77. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
78. Amelioration of adriamycin and daunorubicin myocardial toxicity by adenosine
79. Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart
80. 'Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with In situ nick end-labeling
81. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon
82. Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses
83. Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells
84. Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor
85. p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system
86. Adenosine, antioxidant enzymes and cytoprotection
87. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs
88. DNA double-stranded breaks in mammalian cells after exposure to intercalating agents
89. Qualitative and quantitative aspects of intercalator-induced DNA strand breaks
90. Programmed cell death in the progression of heart failure
91. Cardioprotective effects of adenosine A1 and A3 receptor activation in isolated rat cardiac myocytes under hypoxic condition
92. The role of A1/A3 adenosine receptor activation in reduction of cardiomyocyte injury caused by hypoxic stress
93. Cardioprotective effects of Adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes
94. Molecular cloning and characterization of the human A3 adenosine receptor
95. Pretreatment with ischaemia attenuates acute epirubicin-induced cardiotoxicity in isolated rat hearts
96. Modification by adenosine of the effect of adriamycin on myocardial cells in culture
97. Doxorubicin-induced cardiomyocyte death in culture-necrosis, not apoptosis
98. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol
99. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist
100. Adriamycin-induced leakage of lysosomal enzymes in vitro
101. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells
102. Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity
103. Protein kinase C: Its role in ischemic preconditioning in the rat
104. A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia
105. Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors
106. Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation
107. Ischemic heart disease and apoptosis
108. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction
109. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
110. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II
111. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: Evidence for a G-protein mechanism
112. Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart
113. Enhanced resistance of adriamycin-treated MCR-5 lung fibroblasts by increased intracellular glutathione peroxidase and extracellular antioxidants
114. Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes
115. Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells
116. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I
117. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes
118. Chromatin changes in apoptosis
119. Adenosine A3 receptor agonist protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists
120. Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method
121. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
122. Preconditioning protects ischemic rabbit heart by protein kinase C activation
123. D xorubi i - Induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187
124. Molecular cloning and characterization of an adenosine receptor: The A3 adenosine receptor